# Management of multicausal iatrogenic bile duct injuries with biliary fistula: Twenty-year experience in a tertiary center

**Authors:** Victor Garbay, Jean-Philippe Ratone, Cristophe Zemmour, Solene Hoibian, Yanis Dahel, Anais Palen, Jonathan Garnier, Jacques Ewald, Olivier Turrini, Marc Giovannini, Fabrice Caillol

PMC · DOI: 10.1055/a-2788-3182 · Endoscopy International Open · 2026-02-23

## TL;DR

This paper reports on the successful management of bile duct injuries using endoscopic techniques over 20 years in a specialized center.

## Contribution

The study provides insights into managing complex bile duct injuries, particularly those unrelated to cholecystectomy.

## Key findings

- Endoscopic retrograde cholangiopancreatography (ERCP) alone was efficient in 97.4% of patients.
- The overall success rate for bile duct injury management was 91.8%.
- Strasberg A bile duct injuries had a significantly higher treatment success rate.

## Abstract

Biliary surgery is a common procedure, especially cholecystectomy (CCT). Its main adverse event (AE) is biliary duct injury (BDI). Management is poorly codified, particularly for complex BDIs not related to CCT (NONCCT-BDI). We decided to conduct a study in a tertiary center to evaluate clinical outcomes of BDI management.

A single-center retrospective study of patients diagnosed with a BDI between March 2002 and June 2022 was performed. The primary endpoint was the overall success rate for BDI management. Secondary endpoints were outcomes of BDI related to CCT (CCT-BDI) and non-CCT-BDI according to BDI location, need for a combination of procedures, and AEs.

Sixty-four patients were included. The overall success rate was 91.8%. Endoscopic retrograde cholangiopancreatography (ERCP) alone was efficient in 97.4% of patients. Endoscopy was key to successful treatment in 69% of patients. Forty-five percent of cases were non-CCT-BDI and the treatment success rate was 88.9%. The treatment success rate was significantly higher for Strasberg A BDIs (
P
= 0.0337).

ERCP remains the best and least invasive treatment for hilar injuries, as evidenced by a high success rate. Management of NON-CCT-BDIs should be modeled after that of CCT-BDIs. Owing to the need for a combination of treatments, complex hilar injuries must be managed in expert centers.

## Full-text entities

- **Diseases:** leak (MESH:D019559), biliary peritonitis (MESH:D010538), death (MESH:D003643), choledocholithiasis (MESH:D042883), fistula (MESH:D005402), biliary cirrhosis (MESH:D008105), E4 injury (MESH:C536595), biliary fistula (MESH:D001658), CCT (MESH:D017562), BDI (MESH:D042882), cancer (MESH:D009369), injuries (MESH:D014947), bile duct injuries (MESH:D001649), extrahepatic injury (MESH:D001651), biliary stenosis (MESH:D003251), hilar injuries (MESH:D018285), jaundice (MESH:D007565), Biliary tract injuries (MESH:D001660)
- **Chemicals:** NON (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951037/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951037/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951037/full.md

---
Source: https://tomesphere.com/paper/PMC12951037